President Donald Trump on Thursday announced two new efforts to expand the availability of in vitro fertilization, the first concrete step from his administration on the expensive and politically fraught procedure.

Trump struck a deal with EMD Serono, a subsidiary of Germany's Merck KGaA, to slash the price of some of the company's fertility medicines in exchange for relief from planned tariffs on pharmaceuticals imported into the U.S., which Trump has not yet imposed.

The Trump administration will also be issuing guidance encouraging employers to offer fertility benefits directly to their employees, which would work similarly to vision or dental coverage. It will allow employers to offer add-on coverage at a fixed cost for patients and employers. But it's unclear how much

See Full Page